310 related articles for article (PubMed ID: 31412296)
21. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
[TBL] [Abstract][Full Text] [Related]
22. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
23. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.
Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P
Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181
[TBL] [Abstract][Full Text] [Related]
24. Targeting oncogenic SOX2 in human cancer cells: therapeutic application.
Zhang S; Sun Y
Protein Cell; 2020 Feb; 11(2):82-84. PubMed ID: 31748974
[No Abstract] [Full Text] [Related]
25. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.
Chen J; Chen S; Zhuo L; Zhu Y; Zheng H
Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
27. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.
Gong X; Liu W; Wu L; Ma Z; Wang Y; Yu S; Zhang J; Xie H; Wei G; Ma F; Lu L; Chen L
J Biol Chem; 2018 Nov; 293(48):18646-18654. PubMed ID: 30315105
[TBL] [Abstract][Full Text] [Related]
29. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
30. Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer.
Vaidya M; Sugaya K
PLoS One; 2020; 15(2):e0229309. PubMed ID: 32092088
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes.
Seo S; Jeon HY; Kim H
DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914
[TBL] [Abstract][Full Text] [Related]
32. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response.
Mirzaei S; Paskeh MDA; Entezari M; Mirmazloomi SR; Hassanpoor A; Aboutalebi M; Rezaei S; Hejazi ES; Kakavand A; Heidari H; Salimimoghadam S; Taheriazam A; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Dec; 156():113860. PubMed ID: 36272267
[TBL] [Abstract][Full Text] [Related]
33. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
34. Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer.
Dey A; Kundu M; Das S; Jena BC; Mandal M
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188692. PubMed ID: 35122882
[TBL] [Abstract][Full Text] [Related]
35. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
Ooki A; Dinalankara W; Marchionni L; Tsay JJ; Goparaju C; Maleki Z; Rom WN; Pass HI; Hoque MO
Oncogene; 2018 Nov; 37(45):5967-5981. PubMed ID: 29980786
[TBL] [Abstract][Full Text] [Related]
36. MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.
Ren L; Deng B; Saloura V; Park JH; Nakamura Y
Oncol Rep; 2019 Apr; 41(4):2540-2548. PubMed ID: 30720113
[TBL] [Abstract][Full Text] [Related]
37. SOX2 and squamous cancers.
Porter L; McCaughan F
Semin Cancer Biol; 2020 Dec; 67(Pt 1):154-167. PubMed ID: 32905832
[TBL] [Abstract][Full Text] [Related]
38. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
39. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
40. Role of Oct4-Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cells.
Bigdelou Z; Mortazavi Y; Saltanatpour Z; Asadi Z; Kadivar M; Johari B
Mol Biol Rep; 2020 Mar; 47(3):1859-1869. PubMed ID: 32016633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
